Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Ursodeoxycholic acid combined with total glucosides of paeony
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatitis
1 trial -
Vedolizumab
Second Affiliated Hospital of Soochow University
Ulcerative Colitis (UC)
1 trial -
WARFARIN, LYSINE ASPIRIN, CLOPIDOGREL, ACETYLSALICYLIC ACID, ATORVASTATIN, DILTIAZEM, BISOPROLOL, ACETYLCHOLINE CHLORIDE, GLYCERYL TRINITRATE, RAMIPRIL
Fondazione Telethon ETS
Myocardial infarction with non-obstructive coronary arteries (MINOCA)
1 trial -
conbercept
Hospital Authority, Hong Kong
Polypoidal Choroidal Vasculopathy
1 trial -
minimally invasive cholecystolithotomy with gallbladder reservation
The First People's Hospital of Lianyungang
Gallstones
1 trial -
25% Carbohydrate solution (CHO drinking)
Hospital Authority, Hong Kong
Type2diabetes
1 trial -
Biobanking with genetic analysis
Chongqing Precision Biotech Co., Ltd
Chronic Inflammatory Disease
1 trial -
Blueberry, cranberry, green tea extract, cocoa
United Therapeutics Europe Ltd
Stress, Psychological
1 trial -
CHO+PRO
United Therapeutics Europe Ltd
High Altitude
1 trial -
CMV-VST
Chongqing Precision Biotech Co., Ltd
Cytomegalovirus Viremia
1 trial -
Carrelizumab
The First People's Hospital of Lianyungang
Cholangiocarcinoma
1 trial -
Cholecalciferol
United Therapeutics Europe Ltd
Vitamin D Deficiency
1 trial -
Citrus Limonoid Beverage
United Therapeutics Europe Ltd
Hypercholesterolemia
1 trial -
Dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Bronchoscopy
1 trial -
EchoGo
United Therapeutics Europe Ltd
Coronary Heart Disease
1 trial -
Esketamine, Sulfentanil or/and Remifentanil
Second Affiliated Hospital of Soochow University
Opioid Analgesic Adverse Reaction
1 trial -
Inhaled corticosteriod/long-acting beta-agonist plus Montelukast
Second Affiliated Hospital, School of Medicine, Zhejiang University
Asthma
1 trial -
Itraconazole
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sporotrichosis
1 trial -
Oral Chondroitin Sulfate (Flextrum)
COLLEGIUM PHARMACEUTICAL, INC
Meniscus Lesion
1 trial -
Phase 1 Wonderlab Product
Chongqing Precision Biotech Co., Ltd
Diabetes
1 trial -
QiMeiYan Probiotics
Chongqing Precision Biotech Co., Ltd
IBS - Irritable Bowel Syndrome
1 trial -
Ready-to-use school food
United Therapeutics Europe Ltd
School Attendance
1 trial -
Ringer's solution acetate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cholecystolithiasis and Thyroid Nodule
1 trial -
Study product A (Wonderlab wonder4shape)
Chongqing Precision Biotech Co., Ltd
Overweight and Obesity
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources